BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38029706)

  • 1. Disturbed endothelial cell signaling in tumor progression and therapy resistance.
    Fischer A; Alsina-Sanchis E
    Curr Opin Cell Biol; 2024 Feb; 86():102287. PubMed ID: 38029706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Angiocrine Signaling: Novel Targeting Opportunity in Cancer.
    Oria VO; Erler JT
    Cells; 2023 Oct; 12(20):. PubMed ID: 37887354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor endothelial cells accelerate tumor metastasis.
    Maishi N; Hida K
    Cancer Sci; 2017 Oct; 108(10):1921-1926. PubMed ID: 28763139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular heterogeneity of tumor endothelium.
    Aird WC
    Cell Tissue Res; 2009 Jan; 335(1):271-81. PubMed ID: 18726119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Angiogenesis: Exploiting Angiocrine Factors to Restrict Tumor Progression and Metastasis.
    Singhal M; Augustin HG
    Cancer Res; 2020 Feb; 80(4):659-662. PubMed ID: 31831463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of Tumor Endothelial Cells in Cancer Progression.
    Hida K; Maishi N; Annan DA; Hida Y
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis.
    Song K; Wu H; Rahman HN; Dong Y; Wen A; Brophy ML; Wong S; Kwak S; Bielenberg DR; Chen H
    Cell Mol Life Sci; 2017 Feb; 74(3):393-398. PubMed ID: 27572288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy.
    Haiaty S; Rashidi MR; Akbarzadeh M; Maroufi NF; Yousefi B; Nouri M
    IUBMB Life; 2020 May; 72(5):825-841. PubMed ID: 32026601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvascular endothelial cell heterogeneity: general concepts and pharmacological consequences for anti-angiogenic therapy of cancer.
    Langenkamp E; Molema G
    Cell Tissue Res; 2009 Jan; 335(1):205-22. PubMed ID: 18677515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.
    Maes H; Olmeda D; Soengas MS; Agostinis P
    FEBS J; 2016 Jan; 283(1):25-38. PubMed ID: 26443003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
    Zhao Y; Adjei AA
    Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
    Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular Detransformation for Cancer Therapy.
    Fan Y
    Trends Cancer; 2019 Aug; 5(8):460-463. PubMed ID: 31421902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tie-1: A potential target for anti-angiogenesis therapy.
    Yang P; Chen N; Jia JH; Gao XJ; Li SH; Cai J; Wang Z
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):615-622. PubMed ID: 26489611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes in Angiogenesis and Anti-angiogenic Therapy in Cancers.
    Olejarz W; Kubiak-Tomaszewska G; Chrzanowska A; Lorenc T
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Calcineurin Signaling Restrains Metastatic Outgrowth by Regulating Bmp2.
    Hendrikx S; Coso S; Prat-Luri B; Wetterwald L; Sabine A; Franco CA; Nassiri S; Zangger N; Gerhardt H; Delorenzi M; Petrova TV
    Cell Rep; 2019 Jan; 26(5):1227-1241.e6. PubMed ID: 30699351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium.
    Brantley-Sieders DM; Dunaway CM; Rao M; Short S; Hwang Y; Gao Y; Li D; Jiang A; Shyr Y; Wu JY; Chen J
    Cancer Res; 2011 Feb; 71(3):976-87. PubMed ID: 21148069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical supports from liver cancer cells are essential for differentiation and remodeling of endothelial cells in a HepG2-HUVEC co-culture model.
    Chiew GGY; Fu A; Perng Low K; Qian Luo K
    Sci Rep; 2015 Jun; 5():10801. PubMed ID: 26053957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical role of vascular endothelial growth factor in tumor angiogenesis.
    Amini A; Masoumi Moghaddam S; Morris DL; Pourgholami MH
    Curr Cancer Drug Targets; 2012 Jan; 12(1):23-43. PubMed ID: 22111836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell plasticity at the single-cell level.
    Pasut A; Becker LM; Cuypers A; Carmeliet P
    Angiogenesis; 2021 May; 24(2):311-326. PubMed ID: 34061284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.